(Q74094612)
Statements
Selegiline is ineffective in a collaborative double-blind, placebo-controlled trial for treatment of amyotrophic lateral sclerosis (English)
D J Lange
P L Murphy
B Diamond
V Appel
E C Lai
D S Younger
1 January 1998